You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
Johnson and Johnson
Moodys
Express Scripts

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Cholestyramine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cholestyramine and what is the scope of freedom to operate?

Cholestyramine is the generic ingredient in eight branded drugs marketed by Parke Davis, Ajanta Pharma Ltd, Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Zydus Pharms, Teva Pharms, Allied, Upsher Smith Labs, Bristol Myers, and Apothecon, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Eight suppliers are listed for this compound.

Drug Prices for cholestyramine

See drug prices for cholestyramine

Recent Clinical Trials for cholestyramine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Seoul National University HospitalN/A
EA Pharma Co., Ltd.Phase 2
Yokohama City UniversityPhase 2

See all cholestyramine clinical trials

Pharmacology for cholestyramine

US Patents and Regulatory Information for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074348-001 May 28, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071739-001 May 26, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms CHOLESTYRAMINE cholestyramine POWDER;ORAL 074771-001 Jul 9, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs PREVALITE cholestyramine POWDER;ORAL 073263-002 Oct 30, 1997 AB RX No No   Start Trial   Start Trial   Start Trial
Ajanta Pharma Ltd CHOLESTYRAMINE cholestyramine POWDER;ORAL 211119-002 Apr 6, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms CHOLESTYRAMINE cholestyramine POWDER;ORAL 074771-002 Jul 9, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074555-002 Sep 30, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Baxter
Medtronic
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.